Efficacy and safety of Brentuximab Vedotin in advanced cutaneous T‐Cell lymphomas patients. (28th February 2019) - Papadavid, E.; Kapniari, E.; Marinos, L.; Nikolaou, V.; Oikonomidi, A.; Georgakopoulos, J.; Stratigos, A.; Kouloulias, V.; Pappa, V.